Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36


Factors other than glomerular filtration rate affect serum cystatin C levels.

Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS.

Kidney Int. 2009 Mar;75(6):652-60. doi: 10.1038/ki.2008.638. Epub 2008 Dec 31.


Rapid kidney function decline and mortality risk in older adults.

Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ.

Arch Intern Med. 2008 Nov 10;168(20):2212-8. doi: 10.1001/archinte.168.20.2212.


A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease.

Xie D, Joffe MM, Brunelli SM, Beck G, Chertow GM, Fink JC, Greene T, Hsu CY, Kusek JW, Landis R, Lash J, Levey AS, O'Conner A, Ojo A, Rahman M, Townsend RR, Wang H, Feldman HI.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1332-8. doi: 10.2215/CJN.05631207. Epub 2008 Jul 30.


Waist-to-hip ratio, body mass index, and subsequent kidney disease and death.

Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, Levey AS, Weiner DE.

Am J Kidney Dis. 2008 Jul;52(1):29-38. doi: 10.1053/j.ajkd.2008.02.363. Epub 2008 May 29.


Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.

Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, Levy D, Fox CS.

Am J Kidney Dis. 2008 Jul;52(1):39-48. doi: 10.1053/j.ajkd.2008.03.003. Epub 2008 Apr 28.


Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD 3rd, Zhang YL, Greene T, Levey AS.

Am J Kidney Dis. 2008 Mar;51(3):395-406. doi: 10.1053/j.ajkd.2007.11.018.


Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.

Hallan S, Astor B, Romundstad S, Aasarød K, Kvenild K, Coresh J.

Arch Intern Med. 2007 Dec 10;167(22):2490-6.


Prevalence of chronic kidney disease in the United States.

Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS.

JAMA. 2007 Nov 7;298(17):2038-47.


Excess weight as a risk factor for kidney failure.

Nguyen S, Hsu CY.

Curr Opin Nephrol Hypertens. 2007 Mar;16(2):71-6. Review.


Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, Steffes MW, Weiss NS, Brunzell JD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group.

J Am Soc Nephrol. 2007 Jan;18(1):235-43. Epub 2006 Dec 6.


GFR estimation using cystatin C is not independent of body composition.

Macdonald J, Marcora S, Jibani M, Roberts G, Kumwenda M, Glover R, Barron J, Lemmey A.

Am J Kidney Dis. 2006 Nov;48(5):712-9.


Obesity, proteinuria and progression of renal failure.

Praga M, Morales E.

Curr Opin Nephrol Hypertens. 2006 Sep;15(5):481-6. Review.


Body mass index and risk for end-stage renal disease.

Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS.

Ann Intern Med. 2006 Jan 3;144(1):21-8.


Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society.

Villareal DT, Apovian CM, Kushner RF, Klein S; American Society for Nutrition; NAASO, The Obesity Society.

Am J Clin Nutr. 2005 Nov;82(5):923-34. Review.


Association between body mass index and CKD in apparently healthy men.

Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM.

Am J Kidney Dis. 2005 Nov;46(5):871-80.


Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program.

Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D.

Am J Kidney Dis. 2005 Oct;46(4):587-94.


Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example.

Delanaye P, Radermecker RP, Rorive M, Depas G, Krzesinski JM.

Nephrol Dial Transplant. 2005 Oct;20(10):2024-8. Epub 2005 Jul 19. Review. No abstract available.


Cystatin C and the risk of death and cardiovascular events among elderly persons.

Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C.

N Engl J Med. 2005 May 19;352(20):2049-60.


Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators.

Lancet. 2004 Sep 11-17;364(9438):937-52.


Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2004 May;15(5):1307-15.

Supplemental Content

Support Center